# Study Evaluating Persistence Of Antibody Response Elicited By 13vPnC In Healthy Adults Previously Vaccinated

> **NCT01025336** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 962 (actual)

## Conditions studied

- Healthy

## Interventions

- **OTHER:** Blood draw
- **OTHER:** Blood draw

## Key facts

- **NCT ID:** NCT01025336
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 962 (ACTUAL)
- **Last updated:** 2012-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01025336

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01025336, "Study Evaluating Persistence Of Antibody Response Elicited By 13vPnC In Healthy Adults Previously Vaccinated". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01025336. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*